GALMED PHARMACEUTICALS LTD. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
GALMED PHARMACEUTICALS LTD. (GLMD) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of -$140.00 thousand for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-09-02
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|
| 2026-06-30 | -$140.00K 6-K · filed 2026-09-02 | |
| 2025-06-30 | $19.00K 6-K · filed 2026-09-02 | |
| 2020-12-31 | $527.00K 20-F · filed 2021-03-18 | |
| 2020-06-30 | $10.00K 6-K · filed 2020-08-06 | |
| 2019-12-31 | $9.00K 20-F · filed 2021-03-18 | |
| 2019-06-30 | $9.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | -$12.00K 20-F · filed 2021-03-18 | |
| 2018-06-30 | -$5.00K 6-K · filed 2019-08-05 | |
| 2017-12-31 | -$143.00K 20-F · filed 2020-03-12 | |
| 2017-06-30 | -$115.00K 6-K · filed 2018-08-02 | |
| 2016-12-31 | -$231.00K 20-F · filed 2019-03-13 | |
| 2016-06-30 | -$138.00K 6-K · filed 2017-07-31 | |
| 2015-12-31 | -$50.00K 20-F · filed 2018-03-13 | |
| 2015-06-30 | $0.00 6-K · filed 2017-06-23 | |
| 2014-12-31 | $0.00 20-F · filed 2017-03-23 | |
| 2013-12-31 | $0.00 20-F · filed 2016-03-22 |